Gastro-intestinal permeability is increased in patients with limited systemic sclerosis

Scandinavian Journal of Rheumatology

Volumn 30, Issue 2, 2001, Pages 77-81

  Catanoso, M ^a   Lo Gullo, R ^a   Giofre M R ^a   Pallio, S ^a   Tortora, A ^a   Lo Presti, M ^a   Frisina, N ^a   Bagnato, G ^a   Fries, W ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Acetylsalicylic acid; Gastric permeability; Intestinal permeability; Lactulose; Mannitol; Sucrose; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; LACTULOSE; MANNITOL; SUCROSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER; HUMAN; PERMEABILITY; PRIORITY JOURNAL; STOMACH LESION; STOMACH MUCOSA; SYSTEMIC SCLEROSIS;

ADULT; ASPIRIN; DIGESTIVE SYSTEM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; HUMANS; MIDDLE AGED; PERMEABILITY; SCLERODERMA, LOCALIZED; SUCROSE; UREASE;

EID: 0035081333     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740151095303     Document Type: Article

References (32)

1. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of anti-inflammatory drug
2. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease
3. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis
4. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives
5. Increased intestinal permeability in patients with rheumatoid arthritis: A side-effect of oral non-steroidal antiinflammatory drug therapy?
6. Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis
7. Small intestinal structure and passive permeability in systemic sclerosis
8. Intestinal permeability in Behcet's syndrome
9. Scleroderma presenting as the malabsorption syndrome
10. Steatorrhea in progressive systemic sclerosis (scleroderma)
11. Ultrastructure of the small intestinal mucosa in progressive systemic sclerosis (PSS)
12. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: Ultrastructural study of 3 cases
13. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat
14. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells
15. Effect of non-steroidal anti-inflammatory drugs (NSAID) on intestinal permeability of first degree relatives of patients with Crohn's disease
16. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease
17. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: An inherited defect in mucosal defence?
18. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
19. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
20. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis
21. Lymphocytic gastritis and gastric permeability in patients with celiac disease
22. A simple enzymatic method for the assay of urinary lactulose
23. A method for the determination of mannitol in plasma urine
24. A simple, non-invasive marker of gastric permeability: Sucrose permeability
25. Gastric permeability to sucrose is increased in portal hypertensive gastropathy
26. Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration
27. The differing effects of acute and chronic alcohol on gastric and intestinal permeability
28. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose
29. Increased gastric and intestinal permeability in patients with Crohn's disease
30. Einfluss der magenmotilität auf die messung der magenpermeabilität mittels saccharose in vivo
31. Specificity of human intestinal disaccharidases and implications for hereditary disaccharide intolerance
32. The biochemical basis of nonsteroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and a hypothesis